Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 色谱法 化学
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
灵巧乐儿完成签到,获得积分10
1秒前
酷波er应助wenqing采纳,获得10
1秒前
1秒前
桃井尤川完成签到,获得积分10
2秒前
小小眼发布了新的文献求助10
2秒前
呼呼发布了新的文献求助10
2秒前
1234发布了新的文献求助10
4秒前
Akim应助巴黎的防采纳,获得10
9秒前
谦让大娘完成签到,获得积分10
9秒前
自觉的书蝶完成签到,获得积分10
10秒前
linzhong完成签到,获得积分10
10秒前
Mathea发布了新的文献求助10
11秒前
鱼饼发布了新的文献求助10
12秒前
777发布了新的文献求助10
14秒前
思源应助东风采纳,获得10
16秒前
CodeCraft应助KcNco采纳,获得30
17秒前
20秒前
万能图书馆应助太阳花采纳,获得10
21秒前
随心发布了新的文献求助10
21秒前
21秒前
linzhong发布了新的文献求助10
22秒前
KM完成签到,获得积分0
23秒前
lanjiu完成签到,获得积分10
23秒前
chencf完成签到 ,获得积分10
24秒前
派大星完成签到,获得积分10
24秒前
烦烦发布了新的文献求助20
26秒前
美满诸完成签到,获得积分10
26秒前
27秒前
笨笨岂愈完成签到,获得积分10
27秒前
小蘑菇应助lanjiu采纳,获得10
27秒前
27秒前
28秒前
28秒前
xiaolizi应助呼呼采纳,获得10
29秒前
xiaolizi应助呼呼采纳,获得10
29秒前
30秒前
30秒前
香蕉诗蕊应助舒心牛青采纳,获得10
30秒前
30秒前
太阳花发布了新的文献求助10
32秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
卤化钙钛矿人工突触的研究 1000
Engineering for calcareous sediments : proceedings of the International Conference on Calcareous Sediments, Perth 15-18 March 1988 / edited by R.J. Jewell, D.C. Andrews 1000
Wolffs Headache and Other Head Pain 9th Edition 1000
Continuing Syntax 1000
Signals, Systems, and Signal Processing 510
Effect of Betaine on Growth Performance, Nutrients Digestibility, Blood Cells, Meat Quality and Organ Weights in Broiler Chicks 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6236497
求助须知:如何正确求助?哪些是违规求助? 8060233
关于积分的说明 16818302
捐赠科研通 5316174
什么是DOI,文献DOI怎么找? 2831534
邀请新用户注册赠送积分活动 1808770
关于科研通互助平台的介绍 1665862